💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for DBV Technologies S.A. (DBVT)
« Back to company indexDBVT Chatter Timeline
Stock Ticker for DBVT
Most Active Tweeters for DBVT
| User | Tweets |
|---|---|
| @ConsumerFeed | 5 |
| @ZolmaxNews | 4 |
| @sbwcws | 4 |
| @HealthcareBeat | 3 |
| @WatchlistN | 3 |
Recent Tweets for DBVT
 |
@dispatchtribune DBV TECHNOLOGIE/S $DBVT Downgraded by Zacks Investment Research to “Hold” https://t.co/enRhMvXUMo July 11th 2020, 11:07am |
 |
@TranscriptDaily DBV TECHNOLOGIE/S $DBVT Downgraded by Zacks Investment Research to “Hold” https://t.co/F7UGmQNSmI July 11th 2020, 10:07am |
 |
@manu1r0 $DBVT - DBV Tech's Viaskin Peanut shows benefit in long-term extension study https://t.co/LquhtxRs1q July 11th 2020, 8:07am |
 |
@AlertTrade RT @Briefingcom: $DBVT: DBV Technologies announces that The Journal of Allergy and Clinical Immunology (JACI) has published results... http… July 10th 2020, 1:07pm |
 |
@Briefingcom $DBVT: DBV Technologies announces that The Journal of Allergy and Clinical Immunology (JACI) has published results.… https://t.co/v1DgkmkkWY July 10th 2020, 1:07pm |
|
@Briefingcom $DBVT: DBV Technologies announced that The Journal of Allergy and Clinical Immunology (JACI) has published results.… https://t.co/cRRXku0vpp July 10th 2020, 11:07am |
 |
@HottestStockNow $DBVT Reveals Findings from Late-Stage Open-Label Extension Study Evaluating Viaskin Peanut #DBVTechnologies… https://t.co/KaeFaKGL1v July 10th 2020, 10:07am |
 |
@HealthcareBeat DBV Tech's Viaskin Peanut shows benefit in long-term extension study $DBVT https://t.co/BXRomTTP5A July 10th 2020, 9:07am |
 |
@MarketCurrents $DBVT - DBV Tech's Viaskin Peanut shows benefit in long-term extension study https://t.co/px1jmSP7Oi July 10th 2020, 9:07am |
 |
@otcdynamics $DBVT DBV Technologies Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin https://t.co/NFFRaBHaYQ July 10th 2020, 9:07am |
 |
@BehaviorFin RT @BertrandBio: $DBVT PEOPLE ph3 36mo data of VP for peanut allergy - pre-proof out in JACI $DBV Long-Term, Open-Label Extension Study of… July 10th 2020, 9:07am |
 |
@BertrandBio $DBVT PEOPLE ph3 36mo data of VP for peanut allergy - pre-proof out in JACI $DBV Long-Term, Open-Label Extension S… https://t.co/QKFlBeI9tx July 10th 2020, 9:07am |
 |
@biotechradar_eu $DBV Technologies $DBVT Announces Publication of PEOPLE Phase III Open-Label Extension Study Evaluating Viaskin Pea… https://t.co/uzIvYg74Pt July 10th 2020, 9:07am |
 |
@sbwcws DBV Technologies publishes results from Phase 3 PEPTITES study $DBVT July 10th 2020, 9:07am |
 |
@ConsumerFeed DBV TECHNOLOGIE/S $DBVT Coverage Initiated at JMP Securities https://t.co/AnipXjLa2l July 6th 2020, 7:07am |
 |
@WatchlistN DBV TECHNOLOGIE/S $DBVT Research Coverage Started at JMP Securities https://t.co/koKURHZE7I July 6th 2020, 7:07am |
 |
@ZolmaxNews DBV TECHNOLOGIE/S $DBVT Receives New Coverage from Analysts at JMP Securities https://t.co/vbwCljJhsl July 6th 2020, 6:07am |
|
@WatchlistN BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Sell https://t.co/EO0riU8yYA July 6th 2020, 4:07am |
|
@dakotafinancial BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Sell https://t.co/J8fB5v73un July 5th 2020, 4:07am |
|
@ConsumerFeed BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Sell https://t.co/T375AgQvG3 July 5th 2020, 3:07am |
|
@ZolmaxNews BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Sell https://t.co/GUQuv92SKw July 5th 2020, 3:07am |
 |
@EnterpriseLeade DBV TECHNOLOGIE/S $DBVT Cut to Sell at BidaskClub https://t.co/Phx4xApxvd July 5th 2020, 3:07am |
 |
@ChartMill A Current Ratio of 3.79 indicates that $DBVT has no problem at all paying its short term obligations.… https://t.co/I43jb9E35R July 4th 2020, 11:07pm |
|
@HealthcareBeat Sent packing: Germany sets out to fry the cheap meat trade $DBVT https://t.co/30kSKvqRlh July 3rd 2020, 7:07am |
 |
@BioStocks $DBVT initiated at Overweight at JMP. PT $10 https://t.co/TibiERlbFG July 2nd 2020, 8:07am |
 |
@Gambiste1 RT @sbwcws: JMP Securities positive on DBV Technologies' risk-reward $DBVT July 2nd 2020, 6:07am |
|
@sbwcws JMP Securities positive on DBV Technologies' risk-reward $DBVT July 2nd 2020, 6:07am |
|
@ChartMill $DBVT has a Quick Ratio of 3.75, indicating it is financially healthy. https://t.co/ETCBF9ajUf https://t.co/jL2E8eoJG1 July 1st 2020, 10:07am |
 |
@OlympiaReport DBV TECHNOLOGIE/S $DBVT Lowered to “Hold” at BidaskClub https://t.co/mzUCvHHX9r July 1st 2020, 1:07am |
 |
@WeekHerald DBV TECHNOLOGIE/S $DBVT Lowered to “Hold” at BidaskClub https://t.co/rMmqBVOpy9 July 1st 2020, 1:07am |
 |
@ThisLincolnian DBV TECHNOLOGIE/S $DBVT Receives “Hold” Rating from Stifel Nicolaus https://t.co/k70eW2KHeq June 30th 2020, 3:06am |
 |
@stocknewstimes DBV TECHNOLOGIE/S $DBVT Receives “Hold” Rating from Stifel Nicolaus https://t.co/0B15lx38OM June 30th 2020, 3:06am |
|
@ConsumerFeed DBV TECHNOLOGIE/S $DBVT Receives “Hold” Rating from Stifel Nicolaus https://t.co/HdDcYQTW3c June 30th 2020, 3:06am |
|
@stocknewstimes DBV TECHNOLOGIE/S $DBVT Cut to “Hold” at BidaskClub https://t.co/DhybO4tL4F June 30th 2020, 2:06am |
 |
@Xconomy With Peanut Patch in FDA Purgatory, @DBVTechnologies Plans Layoffs to Stretch Cash - by @sarahdc https://t.co/6uUmZgU0F9 $AIMT $DBVT June 29th 2020, 12:06pm |
|
@dakotafinancial DBV TECHNOLOGIE/S $DBVT – Analysts’ Weekly Ratings Updates https://t.co/10JyfRhYyP June 29th 2020, 11:06am |
|
@ConsumerFeed DBV TECHNOLOGIE/S $DBVT – Analysts’ Weekly Ratings Updates https://t.co/UcniMHYPjn June 29th 2020, 11:06am |
|
@BertrandBio @jq1234t Also it seems the rationale for "no AdCom rescheduling" => "the FDA already made up its mind" => CRL is well set for $DBVT. June 29th 2020, 8:06am |
|
@sbwcws DBV approval likely to be delayed beyond action date, says Citi $DBVT June 29th 2020, 6:06am |
|
@sbwcws DBV Technologies restructuring a proactive step, says H.C. Wainwright $DBVT June 29th 2020, 6:06am |
|
@EnterpriseLeade DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub to Hold https://t.co/1Al4JDAkjQ June 29th 2020, 2:06am |
|
@ZolmaxNews BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Hold https://t.co/qoP7oc55B8 June 29th 2020, 2:06am |
|
@ConsumerFeed BidaskClub Downgrades DBV TECHNOLOGIE/S $DBVT to Hold https://t.co/yZVfKZmljg June 29th 2020, 2:06am |
|
@WatchlistN DBV TECHNOLOGIE/S $DBVT Downgraded by BidaskClub to “Hold” https://t.co/Jhb7b4lBv3 June 28th 2020, 6:06am |
|
@TranscriptDaily DBV TECHNOLOGIE/S $DBVT Rating Lowered to Hold at BidaskClub https://t.co/nUaYTOVpD9 June 28th 2020, 6:06am |
|
@HealthcareBeat Form 6-K (report of foreign issuer [rules 13a-16 and 15d-16]) filed with the SEC $DBVT https://t.co/irUhMTKN28 June 28th 2020, 1:06am |
 |
@AmericanBanking Zacks: Analysts Anticipate DBV TECHNOLOGIE/S $DBVT Will Announce Earnings of -$0.46 Per Share https://t.co/8vi7wB6NnW #stocks June 28th 2020, 1:06am |
 |
@dailypoliticaln Zacks: Analysts Anticipate DBV TECHNOLOGIE/S $DBVT Will Announce Earnings of -$0.46 Per Share https://t.co/IdKpHoMD5P June 28th 2020, 1:06am |
 |
@TickerReport DBV TECHNOLOGIE/S $DBVT Expected to Announce Earnings of -$0.46 Per Share https://t.co/kUI0YUS9yc June 28th 2020, 1:06am |
|
@ZolmaxNews Zacks: Analysts Anticipate DBV TECHNOLOGIE/S $DBVT Will Announce Earnings of -$0.46 Per Share https://t.co/XN5we7qLsT June 28th 2020, 1:06am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2020. All rights reserved.
Make Better Decisions
Finding and Evaluating Generic and Branded Drug Market Entry Opportunities